A groundbreaking international study has demonstrated that monitoring vital sign...
Recent scientific investigations conducted on rodent models have unveiled promis...
In the intricate realm of pediatric surgery, maintaining fluid and electrolyte b...
A groundbreaking study has shed new light on the predictive power of the America...
In a pioneering study poised to redefine the therapeutic landscape for metabolic...
In an era where energy efficiency and environmental sustainability are paramount...
A groundbreaking advancement in point-of-care diagnostics has emerged from the i...
Researchers at the Johns Hopkins Applied Physics Laboratory (APL) have made a gr...
In a groundbreaking leap toward precision medicine, researchers have unveiled a ...
Pathos AI, a clinical-stage biotech company leveraging artificial intelligence t...
The U.S. Food and Drug Administration (FDA) has postponed its decision on Biohav...
Apnimed will be waiting for the readout from a second Phase III trial before it ...
In April 2025, the European Medicines Agency (EMA) approved Eisai and Biogen’s L...
The US FDA has approved Incyte’s Zynyz (retifanlimab-dlwr) in conjunction with c...
Pfizer has signed a worldwide licensing agreement, excluding China, with biophar...
